GRCE vs. AUDUSD=X

Last updated Jul 14, 2026

GRCE (Grace Therapeutics, Inc) is a stock, while AUDUSD=X (AUD/USD) is a currency. Over the past year, GRCE returned -29.46% vs 5.35% for AUDUSD=X. At a 0.11 correlation, their price movements are largely independent.

Performance

GRCE vs. AUDUSD=X - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Grace Therapeutics, Inc (GRCE) and AUD/USD (AUDUSD=X). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GRCE achieves a -29.77% return, which is significantly lower than AUDUSD=X's 3.68% return.

GRCE

• 1D: -0.82%
• 1M: 10.45%
• 6M: -32.50%
• YTD: -29.77%
• 1Y: -29.46%
• 3Y*: —
• 5Y*: —
• 10Y*: —

AUDUSD=X

• 1D: -0.16%
• 1M: -1.76%
• 6M: 3.11%
• YTD: 3.68%
• 1Y: 5.35%
• 3Y*: 0.40%
• 5Y*: -1.54%
• 10Y*: -0.90%

*Multi-year figures are annualized to reflect compound growth (CAGR)

GRCE vs. AUDUSD=X - Yearly Performance Comparison

	2026 (YTD)	2025	2024
GRCE Grace Therapeutics, Inc	-29.77%	-7.49%	22.62%
AUDUSD=X AUD/USD	3.68%	7.81%	-8.39%

Correlation

The correlation between GRCE and AUDUSD=X is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (All Time) Calculated using the full available price history since Oct 8, 2024	0.11

Return for Risk

GRCE vs. AUDUSD=X — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GRCE

GRCE Risk / Return Rank: 28
GRCE Sharpe Ratio Rank: 26
GRCE Sortino Ratio Rank: 32
GRCE Omega Ratio Rank: 31
GRCE Calmar Ratio Rank: 28
GRCE Martin Ratio Rank: 20

AUDUSD=X

AUDUSD=X Risk / Return Rank: 77
AUDUSD=X Sharpe Ratio Rank: 75
AUDUSD=X Sortino Ratio Rank: 75
AUDUSD=X Omega Ratio Rank: 75
AUDUSD=X Calmar Ratio Rank: 80
AUDUSD=X Martin Ratio Rank: 80

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GRCE vs. AUDUSD=X - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Grace Therapeutics, Inc (GRCE) and AUD/USD (AUDUSD=X). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	GRCE	AUDUSD=X	Difference
Sharpe ratio: Return per unit of total volatility	-0.41	0.58	-0.99
Sortino ratio: Return per unit of downside risk	-0.07	0.85	-0.93
Omega ratio: Gain probability vs. loss probability	0.99	1.10	-0.12
Calmar ratio: Return relative to maximum drawdown	-0.50	0.84	-1.34
Martin ratio: Return relative to average drawdown	-1.10	2.12	-3.22

GRCE vs. AUDUSD=X - Sharpe Ratio Comparison

The current GRCE Sharpe Ratio is -0.41, which is lower than the AUDUSD=X Sharpe Ratio of 0.58. The chart below compares the historical Sharpe Ratios of GRCE and AUDUSD=X, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

GRCE vs. AUDUSD=X - Drawdown Comparison

The maximum GRCE drawdown since its inception was -60.00%, which is greater than AUDUSD=X's maximum drawdown of -47.87%. Use the drawdown chart below to compare losses from any high point for GRCE and AUDUSD=X.

Drawdown Indicators

	GRCE	AUDUSD=X	Difference
Max Drawdown Largest peak-to-trough decline	-60.00%	-47.87%	-12.13%
Max Drawdown (1Y) Largest decline over 1 year	-59.06%	-5.12%	-53.94%
Max Drawdown (3Y) Largest decline over 3 years	—	-13.83%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-21.39%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-29.18%	—
Current Drawdown Current decline from peak	-52.63%	-37.19%	-15.44%
Average Drawdown Average peak-to-trough decline	-29.10%	-26.02%	-3.08%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.95%	1.94%	+25.01%

Volatility

GRCE vs. AUDUSD=X - Volatility Comparison

Grace Therapeutics, Inc (GRCE) has a higher volatility of 15.58% compared to AUD/USD (AUDUSD=X) at 1.63%. This indicates that GRCE's price experiences larger fluctuations and is considered to be riskier than AUDUSD=X based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GRCE	AUDUSD=X	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.58%	1.63%	+13.95%
Volatility (6M) Calculated over the trailing 6-month period	78.50%	6.00%	+72.50%
Volatility (1Y) Calculated over the trailing 1-year period	71.51%	7.45%	+64.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	72.08%	10.04%	+62.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.08%	9.58%	+62.50%

Frequently Asked Questions

Can I hold both GRCE and AUDUSD=X in my portfolio?

GRCE and AUDUSD=X have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, GRCE or AUDUSD=X?

GRCE has higher volatility (15.58%) compared to AUDUSD=X (1.63%). In terms of maximum drawdown, GRCE dropped -60.00% vs AUDUSD=X's -47.87%.

Which has better risk-adjusted returns?

AUDUSD=X currently has the higher Sharpe Ratio (0.58 vs -0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.